PMC:7116472 / 297-826 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"12","span":{"begin":6,"end":30},"obj":"Disease"},{"id":"13","span":{"begin":32,"end":40},"obj":"Disease"},{"id":"18","span":{"begin":293,"end":304},"obj":"Species"},{"id":"19","span":{"begin":451,"end":459},"obj":"Species"},{"id":"21","span":{"begin":152,"end":162},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"tao:has_database_id","subj":"12","obj":"MESH:C000657245"},{"id":"A13","pred":"tao:has_database_id","subj":"13","obj":"MESH:C000657245"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Tax:11118"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:9606"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" with coronavirus disease 2019 (covid-19).\n\nDesign\nProspective observational cohort study.\n\nSetting\nInternational Severe Acute Respiratory and emerging Infections Consortium (ISARIC) World Health Organization (WHO) Clinical Characterisation Protocol UK (CCP-UK) study (performed by the ISARIC Coronavirus Clinical Characterisation Consortium—ISARIC-4C) in 260 hospitals across England, Scotland, and Wales. Model training was performed on a cohort of patients recruited between 6 February and 20 May 2020, with validation conduct"}

{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":44,"end":50},"obj":"Sentence"},{"id":"T6","span":{"begin":51,"end":90},"obj":"Sentence"},{"id":"T7","span":{"begin":92,"end":99},"obj":"Sentence"},{"id":"T8","span":{"begin":100,"end":406},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" with coronavirus disease 2019 (covid-19).\n\nDesign\nProspective observational cohort study.\n\nSetting\nInternational Severe Acute Respiratory and emerging Infections Consortium (ISARIC) World Health Organization (WHO) Clinical Characterisation Protocol UK (CCP-UK) study (performed by the ISARIC Coronavirus Clinical Characterisation Consortium—ISARIC-4C) in 260 hospitals across England, Scotland, and Wales. Model training was performed on a cohort of patients recruited between 6 February and 20 May 2020, with validation conduct"}